Basic Information
| RNALocate ID: | RLID:11000759 |
| RNA Symbol: | hsa-miR-21-5p |
| Localization: | Exosome |
RNA Information
| RNA Name: | hsa-miR-21 |
| RNA ID: | miRBase:MIMAT0000076 |
| RNA Category: | miRNA |
| Species: | Homo sapiens |
Localization Information
| PubMed ID: | 26525579 |
| Tissue/Cell Line: | Human bronchial epithelial cells |
| Method: | qRT-PCR |
| Description: | Thus, exosomes from CSE-treated HBE cells contained more miR-21 than those from HBE cells. |
Other Subcellular Localization
| RNALocate ID | Localization | Tissue/Cell line | PubMed ID |
| RLID:01001305 | Cytoplasm | Breast cancer cells (MCF-7) | 27482754 |
| RLID:01001306 | Cytoplasm | Neural progenitor cells | 21363885 |
| RLID:01001307 | Cytoplasm | Cell line (HeLa) | 21695135 |
| RLID:01001308 | Cytoplasm | Breast adenocarcinoma cells (MCF-7)|Cervical adenocarcinoma cells (HeLa) | 24918059 |
| RLID:01001309 | Mitochondrion | Skeletal muscle myoblasts | 21637849 |
| RLID:01001310 | Mitochondrion | Cell line (HEK-293|HeLa) | 22984580 |
| RLID:01001311 | Nucleus | Breast adenocarcinoma cells (MCF-7)|Cervical adenocarcinoma cells (HeLa) | 24918059 |
| RLID:01001312 | Nucleolus | Breast adenocarcinoma cells (MCF-7)|Cervical adenocarcinoma cells (HeLa) | 24918059 |
| RLID:01001313 | Polysome | Human cervical cancer cell line (HeLa) | 25609084 |
| RLID:01001314 | Ribosome | Human glioblastoma cell line (U-87) | 27725160 |
| RLID:11000752 | Apoptotic body | Human umbilical vein endothelial cells | 19996457 |
| RLID:11000753 | Exosome | Lung cancer cell lines (A549|SK-MES) | 22753494 |
| RLID:11000754 | Exosome | Serum | 23224754 |
| RLID:11000755 | Exosome | Cell lines (MCF10A|MCF-7|MDA-MB-231) | 25446899 |
| RLID:11000756 | Exosome | Human cervical carcinoma cell line (HeLa|SiHa) | 25760330 |
| RLID:11000757 | Exosome | NBL cell lines (CHLA-255|IMR-32|SK-N-BE(2)) | 25972604 |
| RLID:11000758 | Exosome | Urine | 26417675 |
| RLID:11000760 | Exosome | Urine | 26576778 |
| RLID:11000761 | Exosome | Esophageal cancer cell line (EC9706) | 27035745 |
| RLID:11000762 | Exosome | EBV- and KSHV-negative Burkitt lymphoma cell line (Bjab)|EBV-infected lymphoblastoid cell line (LCL)|KSHV-infected lymphoma cell lines (BCBL-1|TY-1) | 27611973 |
| RLID:11000763 | Exosome | Plasma | 29143228 |
| RLID:11000764 | Exosome | Human cervical cancer cell line (HeLa) | 29492481 |
| RLID:11000765 | Exosome | HNSCC cell line (FaDu) | 29981499 |
| RLID:11000766 | Exosome | Peripheral blood|Portal vein blood | 30561106 |
| RLID:11000767 | Exosome | BC cell lines (HCC70|MCF-7|MDA-MB-231) | 30728048 |
| RLID:11000768 | Exosome | Extracellular vesicles from the medium of HCC cells (SMMC-7721) | 31037150 |
| RLID:11000769 | Exosome | Glioblastoma cells | 19011622 |
| RLID:11000770 | Exosome | Plasma | 19289371 |
| RLID:11000771 | Exosome | Placenta | 19494253 |
| RLID:11000772 | Exosome | Human embryonic kidney cell line (HEK-293) | 20353945 |
| RLID:11000773 | Exosome | Breast cancer cell line (MCF-7) | 20976003 |
| RLID:11000774 | Exosome | Primary dendritic cells|T cell line (J77) | 21505438 |
| RLID:11000775 | Exosome | Ascites fluid|Pleural effusion | 21601258 |
| RLID:11000776 | Exosome | Breast milk | 22211110 |
| RLID:11000777 | Exosome | Colorectal cancer cell lines (HCT-15|SW480|WiDr) | 22895844 |
| RLID:11000778 | Exosome | Brain tissue | 23382797 |
| RLID:11000779 | Exosome | Plasma | 23663360 |
| RLID:11000780 | Exosome | Human mast cell line (HMC-1) | 24009880 |
| RLID:11000781 | Exosome | Plasma | 24130905 |
| RLID:11000782 | Exosome | Human esophageal cancer cell line (EC9706) | 25184951 |
| RLID:11000783 | Extracellular vesicle | HEK-293T cells | 22849433 |
| RLID:11000784 | Microvesicle | Glioblastoma cells | 19011622 |
| RLID:11000785 | Microvesicle | Plasma | 23077538 |
| RLID:11000786 | Microvesicle | Seminal plasma | 23539611 |
| RLID:11000787 | Microvesicle | Follicular fluid | 23666971 |
| RLID:11000788 | Microvesicle | Hepatoma cells | 23771658 |
| RLID:11000789 | Microvesicle | Serum | 24797360 |
| RLID-D:11000013 | Exosome | Blood|B lymphoblastoid cells|Breast milk|Chronic lymphocytic leukemia cells|Colon tissue|Endothelial cells|Epithelial cells|Kidney tissue|Lymphoma tissue|Mast cells|Saliva|Seminal fluid|Tongue tissue | |
| RLID-D:11000275 | Microvesicle | Blood|Breast cell line|Colon cancer cell line (LIM1863)|Fibroblasts|Mesenchymal stem cells|Urine |
ncRNA Disease Information
| Resource | RNA Symbol | Disease | Link |
| MNDR | hsa-miR-21-5p | Idiopathic pulmonary fibrosis | MNDR-E-MI-29347 |
| MNDR | hsa-miR-21-5p | Diffuse large b cell lymphoma | MNDR-E-MI-29348 |
| MNDR | hsa-miR-21-5p | Splenic marginal zone lymphoma | MNDR-E-MI-29349 |
| MNDR | hsa-miR-21-5p | Multiple sclerosis chronic progressive | MNDR-E-MI-29350 |
| MNDR | hsa-miR-21-5p | Renal fibrosis | MNDR-E-MI-29351 |
| MNDR | hsa-miR-21-5p | Tongue squamous cell carcinoma | MNDR-E-MI-29352 |
| MNDR | hsa-miR-21-5p | Oral squamous cell carcinoma | MNDR-E-MI-29353 |
| MNDR | hsa-miR-21-5p | Large cell neuroendocrine cancer | MNDR-E-MI-29354 |
| MNDR | hsa-miR-21-5p | Medulloblastoma | MNDR-E-MI-29355 |
| MNDR | hsa-miR-21-5p | B cell lymphoma of malt type | MNDR-E-MI-29356 |
| MNDR | hsa-miR-21-5p | Uterine corpus endometrial carcinoma | MNDR-E-MI-29357 |
| MNDR | hsa-miR-21-5p | Lymphoma | MNDR-E-MI-29358 |
| MNDR | hsa-miR-21-5p | Lymphoma non-hodgkin | MNDR-E-MI-29359 |
| MNDR | hsa-miR-21-5p | Estrogen-receptor positive breast cancer | MNDR-E-MI-29360 |
| MNDR | hsa-miR-21-5p | Estrogen-receptor negative breast cancer | MNDR-E-MI-29361 |
| MNDR | hsa-miR-21-5p | Progesterone-receptor positive breast cancer | MNDR-E-MI-29362 |
| MNDR | hsa-miR-21-5p | Progesterone-receptor negative breast cancer | MNDR-E-MI-29363 |
| MNDR | hsa-miR-21-5p | Her2-receptor positive breast cancer | MNDR-E-MI-29364 |
| MNDR | hsa-miR-21-5p | Triple negative breast cancer | MNDR-E-MI-29365 |
| MNDR | hsa-miR-21-5p | Acute promyelocytic leukemia | MNDR-E-MI-29366 |
| MNDR | hsa-miR-21-5p | Perlman syndrome | MNDR-E-MI-29367 |
| MNDR | hsa-miR-21-5p | Bone disease | MNDR-E-MI-29368 |
| MNDR | hsa-miR-21-5p | Precursor cell lymphoblastic leukemia-lymphoma | MNDR-E-MI-29369 |
| MNDR | hsa-miR-21-5p | Thyroid carcinoma anaplastic | MNDR-E-MI-29370 |
| MNDR | hsa-miR-21-5p | Neurofibromatosis 2 | MNDR-E-MI-29371 |
| MNDR | hsa-miR-21-5p | Dermatomyositis | MNDR-E-MI-29372 |
| MNDR | hsa-miR-21-5p | Prostate cancer | MNDR-E-MI-29373 |
| MNDR | hsa-miR-21-5p | Gastric cancer | MNDR-E-MI-29374 |
| MNDR | hsa-miR-21-5p | Gastric lymphoma | MNDR-E-MI-29375 |
| MNDR | hsa-miR-21-5p | Alzheimer disease | MNDR-E-MI-29376 |
| MNDR | hsa-miR-21-5p | Hypertension | MNDR-E-MI-29377 |
| MNDR | hsa-miR-21-5p | Intracranial aneurysm | MNDR-E-MI-29378 |
| MNDR | hsa-miR-21-5p | Bladder cancer | MNDR-E-MI-29379 |
| MNDR | hsa-miR-21-5p | Esophageal carcinoma | MNDR-E-MI-29380 |
| MNDR | hsa-miR-21-5p | Sarcoma | MNDR-E-MI-29381 |
| MNDR | hsa-miR-21-5p | Heart disease | MNDR-E-MI-29382 |
| MNDR | hsa-miR-21-5p | Dysautonomia familial | MNDR-E-MI-29383 |
| MNDR | hsa-miR-21-5p | Duchenne muscular dystrophy | MNDR-E-MI-29384 |
| MNDR | hsa-miR-21-5p | Facioscapulohumeral muscular dystrophy | MNDR-E-MI-29385 |
| MNDR | hsa-miR-21-5p | Seizures | MNDR-E-MI-29386 |
| MNDR | hsa-miR-21-5p | Head and neck cancer | MNDR-E-MI-29387 |
| MNDR | hsa-miR-21-5p | Dengue disease | MNDR-E-MI-29388 |
| MNDR | hsa-miR-21-5p | Malaria | MNDR-E-MI-29389 |
| MNDR | hsa-miR-21-5p | Leukemia | MNDR-E-MI-29390 |
| MNDR | hsa-miR-21-5p | Vestibular schwannoma | MNDR-E-MI-29391 |
| MNDR | hsa-miR-21-5p | Cardiovascular disease | MNDR-E-MI-29392 |
| MNDR | hsa-miR-21-5p | Moyamoya disease | MNDR-E-MI-29393 |
| MNDR | hsa-miR-21-5p | Brain cancer | MNDR-E-MI-29394 |
| MNDR | hsa-miR-21-5p | Uterine fibroid | MNDR-E-MI-29395 |
| MNDR | hsa-miR-21-5p | Lung cancer | MNDR-E-MI-29396 |
| MNDR | hsa-miR-21-5p | Giant cell arteritis | MNDR-E-MI-29397 |
| MNDR | hsa-miR-21-5p | Kawasaki disease | MNDR-E-MI-29398 |
| MNDR | hsa-miR-21-5p | Tuberous sclerosis | MNDR-E-MI-29399 |
| MNDR | hsa-miR-21-5p | Eosinophilic esophagitis | MNDR-E-MI-29400 |
| MNDR | hsa-miR-21-5p | Down syndrome | MNDR-E-MI-29401 |
| MNDR | hsa-miR-21-5p | Fragile x syndrome | MNDR-E-MI-29402 |
| MNDR | hsa-miR-21-5p | Parkinson disease | MNDR-E-MI-29403 |
| MNDR | hsa-miR-21-5p | Colon carcinoma | MNDR-E-MI-29404 |
| MNDR | hsa-miR-21-5p | Breast cancer | MNDR-E-MI-29405 |
| MNDR | hsa-miR-21-5p | Squamous cell carcinoma | MNDR-E-MI-29406 |
| MNDR | hsa-miR-21-5p | Vascular diseases | MNDR-E-MI-29407 |
| MNDR | hsa-miR-21-5p | Thyroid cancer | MNDR-E-MI-29408 |
| MNDR | hsa-miR-21-5p | Pituitary neoplasms | MNDR-E-MI-29409 |
| MNDR | hsa-miR-21-5p | Pancreatic cancer | MNDR-E-MI-29410 |
| MNDR | hsa-miR-21-5p | HCV | MNDR-E-MI-29411 |
| MNDR | hsa-miR-21-5p | Melanoma | MNDR-E-MI-29412 |
| MNDR | hsa-miR-21-5p | Atherosclerosis | MNDR-E-MI-29413 |
| MNDR | hsa-miR-21-5p | Rectal cancer | MNDR-E-MI-29414 |
| MNDR | hsa-miR-21-5p | Rectum cancer | MNDR-E-MI-29415 |
| MNDR | hsa-miR-21-5p | Rectum adenocarcinoma | MNDR-E-MI-29416 |
| MNDR | hsa-miR-21-5p | Nephroblastoma | MNDR-E-MI-29417 |
| MNDR | hsa-miR-21-5p | Colon cancer | MNDR-E-MI-29418 |
| MNDR | hsa-miR-21-5p | Ischemic attack transient | MNDR-E-MI-29419 |
| MNDR | hsa-miR-21-5p | Colon adenocarcinoma | MNDR-E-MI-29420 |
| MNDR | hsa-miR-21-5p | Multiple sclerosis | MNDR-E-MI-29421 |
| MNDR | hsa-miR-21-5p | Multiple sclerosis relapsing-remitting | MNDR-E-MI-29422 |
| MNDR | hsa-miR-21-5p | Familial ovarian cancer | MNDR-E-MI-29423 |
| MNDR | hsa-miR-21-5p | Prostate adenocarcinoma | MNDR-E-MI-29424 |
| MNDR | hsa-miR-21-5p | Laryngeal carcinoma | MNDR-E-MI-29425 |
| MNDR | hsa-miR-21-5p | Kidney cancer | MNDR-E-MI-29426 |
| MNDR | hsa-miR-21-5p | Asthma | MNDR-E-MI-29427 |
| MNDR | hsa-miR-21-5p | Laryngeal squamous cell carcinoma | MNDR-E-MI-29428 |
| MNDR | hsa-miR-21-5p | Carcinoma ductal breast | MNDR-E-MI-29429 |
| MNDR | hsa-miR-21-5p | Breast malignant phyllodes tumor | MNDR-E-MI-29430 |
| MNDR | hsa-miR-21-5p | Acute kidney injury | MNDR-E-MI-29431 |
| MNDR | hsa-miR-21-5p | Glioblastoma | MNDR-E-MI-29432 |
| MNDR | hsa-miR-21-5p | Astrocytoma | MNDR-E-MI-29433 |
| MNDR | hsa-miR-21-5p | Glioma | MNDR-E-MI-29434 |
| MNDR | hsa-miR-21-5p | Oligodendroglioma | MNDR-E-MI-29435 |
| MNDR | hsa-miR-21-5p | Central nervous system lymphoma | MNDR-E-MI-29436 |
| MNDR | hsa-miR-21-5p | Amyotrophic lateral sclerosis | MNDR-E-MI-29437 |
| MNDR | hsa-miR-21-5p | Epilepsy temporal lobe | MNDR-E-MI-29438 |
| MNDR | hsa-miR-21-5p | Osteosarcoma | MNDR-E-MI-29439 |
| MNDR | hsa-miR-21-5p | Coronary artery disease | MNDR-E-MI-29440 |
| MNDR | hsa-miR-21-5p | Inclusion body myositis | MNDR-E-MI-29441 |
| MNDR | hsa-miR-21-5p | Breast carcinoma | MNDR-E-MI-29442 |
| MNDR | hsa-miR-21-5p | Pancreatic ductal adenocarcinoma | MNDR-E-MI-29443 |
| MNDR | hsa-miR-21-5p | Infarction middle cerebral artery | MNDR-E-MI-29444 |
| MNDR | hsa-miR-21-5p | Meningioma | MNDR-E-MI-29445 |
| MNDR | hsa-miR-21-5p | Liver cancer | MNDR-E-MI-29446 |
| MNDR | hsa-miR-21-5p | Uterine cancer | MNDR-E-MI-29447 |
| MNDR | hsa-miR-21-5p | Cervical adenocarcinoma | MNDR-E-MI-29448 |
| MNDR | hsa-miR-21-5p | Gastric adenocarcinoma | MNDR-E-MI-29449 |
| MNDR | hsa-miR-21-5p | Cervical squamous carcinoma | MNDR-E-MI-29450 |
| MNDR | hsa-miR-21-5p | Pituitary adenoma | MNDR-E-MI-29451 |
| MNDR | hsa-miR-21-5p | Lung squamous cell carcinoma | MNDR-E-MI-29452 |
| MNDR | hsa-miR-21-5p | Carcinoma lung non-small-cell | MNDR-E-MI-29453 |
| MNDR | hsa-miR-21-5p | Lung adenocarcinoma | MNDR-E-MI-29454 |
| MNDR | hsa-miR-21-5p | Adrenocortical cancer | MNDR-E-MI-29455 |
| MNDR | hsa-miR-21-5p | Thyroid carcinoma | MNDR-E-MI-29456 |
| MNDR | hsa-miR-21-5p | Papillary thyroid carcinoma | MNDR-E-MI-29457 |
| MNDR | hsa-miR-21-5p | Thyroid medullary carcinoma | MNDR-E-MI-29458 |
| MNDR | hsa-miR-21-5p | Bladder urothelial carcinoma | MNDR-E-MI-29459 |
| MNDR | hsa-miR-21-5p | Pancreatic adenocarcinoma | MNDR-E-MI-29460 |
| MNDR | hsa-miR-21-5p | Intrastent restenosis | MNDR-E-MI-29461 |
| MNDR | hsa-miR-21-5p | Myasthenia gravis autoimmune experimental | MNDR-E-MI-29462 |
| MNDR | hsa-miR-21-5p | Carcinoma renal cell | MNDR-E-MI-29463 |
| MNDR | hsa-miR-21-5p | Kidney renal papillary cell carcinoma | MNDR-E-MI-29464 |
| MNDR | hsa-miR-21-5p | Clear cell renal cell cancer | MNDR-E-MI-29465 |
| MNDR | hsa-miR-21-5p | Large cell carcinoma | MNDR-E-MI-29466 |
| MNDR | hsa-miR-21-5p | Biliary tract cancer | MNDR-E-MI-29467 |
| MNDR | hsa-miR-21-5p | Adenocarcinoma of esophagus | MNDR-E-MI-29468 |
| MNDR | hsa-miR-21-5p | Intrahepatic cholangiocarcinoma | MNDR-E-MI-29469 |
| MNDR | hsa-miR-21-5p | Cholangiocarcinoma | MNDR-E-MI-29470 |
| MNDR | hsa-miR-21-5p | Esophageal cancer | MNDR-E-MI-29471 |
| MNDR | hsa-miR-21-5p | Liver cirrhosis | MNDR-E-MI-29472 |
| MNDR | hsa-miR-21-5p | Lung small cell carcinoma | MNDR-E-MI-29473 |
| MNDR | hsa-miR-21-5p | Stomach carcinoma | MNDR-E-MI-29474 |
| MNDR | hsa-miR-21-5p | Head and neck squamous cell carcinoma | MNDR-E-MI-29475 |
| MNDR | hsa-miR-21-5p | T acute lymphoblastic leukemia | MNDR-E-MI-29476 |
| MNDR | hsa-miR-21-5p | Acute t cell leukemia | MNDR-E-MI-29477 |
| MNDR | hsa-miR-21-5p | Malignant peripheral nerve sheath tumor | MNDR-E-MI-29478 |
| MNDR | hsa-miR-21-5p | Heart failure | MNDR-E-MI-29479 |
| MNDR | hsa-miR-21-5p | Fibromyalgia | MNDR-E-MI-29480 |
| MNDR | hsa-miR-21-5p | Cowden disease | MNDR-E-MI-29481 |
| MNDR | hsa-miR-21-5p | Breast invasive carcinoma | MNDR-E-MI-29482 |
| MNDR | hsa-miR-21-5p | Endometrioid endometrial cancer | MNDR-E-MI-29483 |
| MNDR | hsa-miR-21-5p | Hepatocellular carcinoma | MNDR-E-MI-29484 |
| MNDR | hsa-miR-21-5p | Familiar ovarian carcinoma | MNDR-E-MI-29485 |
| MNDR | hsa-miR-21-5p | B-cell lymphoma | MNDR-E-MI-29486 |
| MNDR | hsa-miR-21-5p | Rheumatoid arthritis | MNDR-E-MI-29487 |
| MNDR | hsa-miR-21-5p | T-cell leukemia | MNDR-E-MI-29488 |
| MNDR | hsa-miR-21-5p | Cervical carcinoma | MNDR-E-MI-29489 |
| MNDR | hsa-miR-21-5p | Neuroblastoma | MNDR-E-MI-29490 |
| MNDR | hsa-miR-21-5p | Chronic kidney disease | MNDR-E-MI-29491 |
| MNDR | hsa-miR-21-5p | Barrett's adenocarcinoma | MNDR-E-MI-29492 |
| MNDR | hsa-miR-21-5p | Periodontitis | MNDR-E-MI-29493 |
| MNDR | hsa-miR-21-5p | Chronic fatigue syndrome | MNDR-E-MI-29494 |
| MNDR | hsa-miR-21-5p | Chronic myelogenous leukemia | MNDR-E-MI-29495 |
| MNDR | hsa-miR-21-5p | Oropharynx cancer | MNDR-E-MI-29496 |
| MNDR | hsa-miR-21-5p | Hodgkin lymphoma | MNDR-E-MI-29497 |
| MNDR | hsa-miR-21-5p | Ulcerative colitis | MNDR-E-MI-29498 |
| MNDR | hsa-miR-21-5p | Burkitt lymphoma | MNDR-E-MI-29499 |
| MNDR | hsa-miR-21-5p | Mouth neoplasms | MNDR-E-MI-29500 |
| MNDR | hsa-miR-21-5p | Cholesteatoma | MNDR-E-MI-29501 |
| MNDR | hsa-miR-21-5p | Crohn disease | MNDR-E-MI-29502 |
| MNDR | hsa-miR-21-5p | Tonsil cancer | MNDR-E-MI-29503 |
| MNDR | hsa-miR-21-5p | Neuromyelitis optica | MNDR-E-MI-29504 |
| MNDR | hsa-miR-21-5p | Systemic lupus erythematosus | MNDR-E-MI-29505 |
| MNDR | hsa-miR-21-5p | Acute myelogenous leukemia | MNDR-E-MI-29506 |
| MNDR | hsa-miR-21-5p | Colorectal cancer | MNDR-E-MI-29507 |
| MNDR | hsa-miR-21-5p | Diabetes mellitus | MNDR-E-MI-29508 |
| MNDR | hsa-miR-21-5p | Type 2 diabetes mellitus | MNDR-E-MI-29509 |
| MNDR | hsa-miR-21-5p | Brain disease | MNDR-E-MI-29510 |
| MNDR | hsa-miR-21-5p | Multiple myeloma | MNDR-E-MI-29511 |
| MNDR | hsa-miR-21-5p | Acute lymphocytic leukemia | MNDR-E-MI-29512 |
| MNDR | hsa-miR-21-5p | Hyaloideoretinal degeneration of wagner | MNDR-E-MI-29513 |
| MNDR | hsa-miR-21-5p | Ovarian epithelial cancer | MNDR-E-MI-29514 |
| MNDR | hsa-miR-21-5p | Esophageal squamous cell carcinoma | MNDR-E-MI-29515 |
| MNDR | hsa-miR-21-5p | Uterine cervical neoplasms | MNDR-E-MI-29516 |
| MNDR | hsa-miR-21-5p | Cicatrix | MNDR-E-MI-29517 |
| MNDR | hsa-miR-21-5p | Diabetic nephropathies | MNDR-E-MI-29518 |
| MNDR | hsa-miR-21-5p | Ependymoma | MNDR-E-MI-29519 |
| MNDR | hsa-miR-21-5p | Cardiomegaly | MNDR-E-MI-29520 |
| MNDR | hsa-miR-21-5p | Inflammation | MNDR-E-MI-29521 |
| MNDR | hsa-miR-21-5p | Nasopharyngeal cancer | MNDR-E-MI-29522 |
| MNDR | hsa-miR-21-5p | Prostatic neoplasms | MNDR-E-MI-29523 |
| MNDR | hsa-miR-21-5p | Pseudorabies | MNDR-E-MI-29524 |
| MNDR | hsa-miR-21-5p | Wounds and injuries | MNDR-E-MI-29525 |
| MNDR | hsa-miR-21-5p | Polymyositis | MNDR-E-MI-29526 |
| MNDR | hsa-miR-21-5p | Epstein-barr virus infections | MNDR-E-MI-29527 |
| MNDR | hsa-miR-21-5p | Cerebral hemorrhage traumatic | MNDR-E-MI-29528 |
| MNDR | hsa-miR-21-5p | Subarachnoid hemorrhage traumatic | MNDR-E-MI-29529 |
| MNDR | hsa-miR-21-5p | Brain injury chronic | MNDR-E-MI-29530 |
| MNDR | hsa-miR-21-5p | Intracranial hemorrhage hypertensive | MNDR-E-MI-29531 |
| MNDR | hsa-miR-21-5p | Pituitary acth hypersecretion | MNDR-E-MI-29532 |
| MNDR | hsa-miR-21-5p | Stroke lacunar | MNDR-E-MI-29533 |
| MNDR | hsa-miR-21-5p | Non-alcoholic fatty liver disease | MNDR-E-MI-29534 |
| MNDR | hsa-miR-21-5p | Barrett's carcinogenesis | MNDR-E-MI-29535 |
| MNDR | hsa-miR-21-5p | Brain metastasis | MNDR-E-MI-29536 |
| MNDR | hsa-miR-21-5p | Breast cancer her3+ negative | MNDR-E-MI-29537 |
| MNDR | hsa-miR-21-5p | Duke A | MNDR-E-MI-29538 |
RNA Interaction Information
| Resource | RNA Symbol | Species | Link | RNALocate ID |
| RNAInter | ABCB1 | Homo sapiens | RR00022780 |
TOP